Americana Partners LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 2,412.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 86,136 shares of the company's stock after acquiring an additional 82,708 shares during the quarter. Americana Partners LLC's holdings in Colgate-Palmolive were worth $7,831,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of CL. Financiere des Professionnels Fonds d investissement inc. boosted its position in Colgate-Palmolive by 16.7% during the fourth quarter. Financiere des Professionnels Fonds d investissement inc. now owns 6,912 shares of the company's stock worth $628,000 after purchasing an additional 990 shares during the period. Sierra Ocean LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $61,000. MOKAN Wealth Management Inc. bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $541,000. Hourglass Capital LLC boosted its holdings in Colgate-Palmolive by 60.9% in the 4th quarter. Hourglass Capital LLC now owns 3,700 shares of the company's stock worth $336,000 after buying an additional 1,400 shares during the period. Finally, Allworth Financial LP boosted its holdings in Colgate-Palmolive by 20.6% in the 4th quarter. Allworth Financial LP now owns 21,584 shares of the company's stock worth $1,890,000 after buying an additional 3,694 shares during the period. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Trading Up 0.4 %
Shares of CL traded up $0.38 during trading hours on Thursday, reaching $87.80. 3,252,724 shares of the company traded hands, compared to its average volume of 4,889,062. Colgate-Palmolive has a 12 month low of $84.45 and a 12 month high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company's fifty day moving average price is $89.13 and its two-hundred day moving average price is $96.05. The company has a market capitalization of $71.25 billion, a price-to-earnings ratio of 24.94, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the company earned $0.87 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.76 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.28%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's payout ratio is currently 56.82%.
Analyst Ratings Changes
Several research analysts recently commented on the stock. StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Barclays cut their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. Stifel Nicolaus lowered their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research report on Monday, February 3rd. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $101.16.
View Our Latest Analysis on CL
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.